Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
164.25 USD
0.52%
Market Closed
Updated:
Apr 18, 2024
Abbvie Inc
PP&E Gross
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
PP&E Gross Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
PP&E Gross
$5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Seagen Inc
NASDAQ:SGEN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's PP&E Gross?
PP&E Gross
5B
USD
5B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's PP&E Gross amounts to 5B USD.
What is Abbvie Inc's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
8%
8%
Over the last year, the PP&E Gross growth was 1%. The average annual PP&E Gross growth rates for Abbvie Inc have been -2% over the past three years , 12% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
